Sfoglia per AUTORE
GELSOMINO F
Collezione AOU San Luigi di Orbassano

  

Items : 11

A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Sep;208:114129. doi: 10.1016/j.ejca.2024.114129. Epub 2024 May 25.
2024
AOU San Luigi di Orbassano

Bongiovanni A; Liverani C; Foca F; Bergamo F; Leo S; Pusceddu S; Gelsomino F; Brizzi MP; Di Meglio G; Spada F; Tamberi S; Lolli I; Cives M; Marconcini R; Pucci F; Berardi R; Antonuzzo L; Badalamenti G; Santini D; Recine F; Vanni S; Tebaldi M; Severi S; Rudnas B; Nanni O; Ranallo N; Crudi L; Calabrò L; Ibrahim T; et alii...

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Salerno F; Camerini A; Carta A; Follador A; Berardi R; Toschi L; Zoratto F; Cortinovis DL; Citarella F; Bulotta A; Rastelli F; Adamo V; Guida A; Manzo A; Cecere FL; Belluomini L; Roca E; Pasello G; Cerea G; Montrone M; Delcuratolo MD; Passiglia F; Guaitoli G; Bertolini F; Genova C; Caliman E; Mazzoni F; Siringo M; Gelibter A; et alii...

A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome. in Tumori / Tumori. 2024 Dec;110(6):NP5-NP10. doi: 10.1177/03008916241255485. Epub 2024 May 23.
2024
AOU San Luigi di Orbassano

Cognigni V; Capelletto E; Bordi P; Pavese V; Carfì FM; Gelsomino F; De Giglio A; Chiari R; Minari R; Ambrosini E; Percesepe A; Giachino D; Bironzo P; Tiseo M;

Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Dec;213:115085. doi: 10.1016/j.ejca.2024.115085. Epub 2024 Oct 28.
2024
AOU San Luigi di Orbassano

Sini C; Di Federico A; Bironzo P; De Giglio A; Gelsomino F;

2024
AOU San Luigi di Orbassano

Panzuto F; Andrini E; Lamberti G; Pusceddu S; Rinzivillo M; Gelsomino F; Raimondi A; Bongiovanni A; Davì MV; Cives M; Brizzi MP; Persano I; Zatelli MC; Puliafito I; Tafuto S; Campana D;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). in Journal of endocrinological investigation / J Endocrinol Invest. 2021 May;44(5):989-994. doi: 10.1007/s40618-020-01393-4. Epub 2020 Aug 16.
2021
AOU San Luigi di Orbassano

Panzuto F; Maccauro M; Campana D; Faggiano A; Massironi S; Pusceddu S; Spada F; Ferone D; Modica R; Grana CM; Ferolla P; Rinzivillo M; Badalamenti G; Zatelli MC; Gelsomino F; De Carlo E; Bartolomei M; Brizzi MP; Cingarlini S; Versari A; Fanciulli G; Arvat E; Merola E; Cives M; Tafuto S; Baldari S; Falconi M; Panzuto F; Maccauro M; et alii...

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis. in Journal of clinical medicine / J Clin Med. 2020 May 5;9(5):1351. doi: 10.3390/jcm9051351.
2020
AOU San Luigi di Orbassano

Lamberti G; Brizzi MP; Pusceddu S; Gelsomino F; Di Meglio G; Massari F; Badalamenti G; Riccardi F; Ibrahim T; Ciccarese C; Buti S; Carnaghi C; Prinzi N; Panzuto F; Campana D;

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz035. doi: 10.1210/clinem/dgz035.
2020
AOU San Luigi di Orbassano

Lamberti G; Faggiano A; Brighi N; Tafuto S; Ibrahim T; Brizzi MP; Pusceddu S; Albertelli M; Massironi S; Panzuto F; Badalamenti G; Riccardi F; Butturini G; Gelsomino F; De Divitiis C; Modica R; Bongiovanni A; La Salvia A; Torchio M; Colao A; Ferone D; Campana D;

Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Jul 20;12:1758835920915983. doi: 10.1177/1758835920915983. eCollection 2020
2020
AOU San Luigi di Orbassano

Gelsomino F; Lamberti G; Tiseo M; Rocco D; Pasello G; Cecere FL; Chella A; Grilli G; Mandruzzato M; Tognetto M; Garassino MC; Macerelli M; Novello S; Roila F; Colantonio I; Grossi F; Fiorentino M; Ardizzoni A;

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2018 Mar;18(2):198-203. doi: 10.1016/j.pan.2018.01.005. Epub 2018 Jan 12.
2018
AOU San Luigi di Orbassano

Rinzivillo M; Fazio N; Pusceddu S; Spallanzani A; Ibrahim T; Campana D; Marconcini R; Partelli S; Badalamenti G; Brizzi MP; Catena L; Schinzari G; Carnaghi C; Berardi R; Faggiano A; Antonuzzo L; Spada F; Gritti S; Femia D; Gelsomino F; Bongiovanni A; Ricci S; Brighi N; Falconi M; Delle Fave G; Panzuto F;